TP53 and gastric cancer: Therefore, by observing the decrease of mutant p53 protein expression after QLSP treatment, we confirmed that QLSP significantly inhibited the intestinal metaplasia of CAG, and we inferred that QLSP could inhibit the transformation of CAG to gastric cancer.